<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease (BD) is a <z:hpo ids='HP_0011010'>chronic</z:hpo>, <z:hpo ids='HP_0003676'>progressive disorder</z:hpo> that affects many systems of the body including the eye </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to assess whether the increase in <z:mp ids='MP_0003674'>oxidative stress</z:mp> in the affected tissues is reflected by <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation and to check for alterations in <z:chebi fb="11" ids="22586">antioxidants</z:chebi> and <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzyme activities in patients with BD </plain></SENT>
<SENT sid="2" pm="."><plain>Erythrocyte <z:chebi fb="11" ids="22586">antioxidant</z:chebi> potential (AOP), <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH) and GSH-dependent enzymes (<z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase (GSH-Px), <z:chebi fb="0" ids="16856">glutathione</z:chebi> reductase (GRD) and <z:chebi fb="0" ids="16856">glutathione</z:chebi>-S-transferase (GST), catalase (CAT), Cu-Zn <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (Cu-Zn SOD) activities, malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>) and some trace elements (zinc, Zn; copper, Cu; <z:chebi fb="70" ids="18291,35154">manganese</z:chebi>, Mn) levels in men with BD </plain></SENT>
<SENT sid="3" pm="."><plain>Erythrocyte CAT, GSH-Px activities, <z:chebi fb="14" ids="32506">MDA</z:chebi>, GSH, AOP and serum Zn values were significantly lower in patients with BD than in the control group </plain></SENT>
<SENT sid="4" pm="."><plain>However, erythrocyte Cu-Zn SOD, GRD activities, erythrocyte sedimentation rate (ESR), serum C-reactive protein (CRP) and Cu values were significantly higher in patients with BD than in the control group, but GST activity and serum Mn values were unchanged </plain></SENT>
<SENT sid="5" pm="."><plain>In conclusion, our results confirm the presence of <z:mp ids='MP_0003674'>oxidative stress</z:mp> in patients with BD and suggest that the severity of BD may arise from impaired <z:chebi fb="11" ids="22586">antioxidant</z:chebi> mechanisms </plain></SENT>
<SENT sid="6" pm="."><plain>Therapy with <z:chebi fb="11" ids="22586">antioxidants</z:chebi> may lead to the increase in the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> defense system and thus improvement in clinical symptoms </plain></SENT>
</text></document>